Skip to main content

Table 1 Comorbidities under treatment at baseline and after 12 months aspiration therapy

From: Aspiration therapy for obesity; a safe and effective treatment

Comorbidities under treatment
Number of subjects
Baseline, all subjects
n = 25
Baseline, per protocol
n = 20
12 months, per protocol
n = 20
Diabetes mellitus type 2 (total) 7 7 5
 - Diet treatment 2 2 2
 - Metformin 4 4 2
 - Metformin + insulin 1 1 1
Hypertension (total) 9 8 7
 - Diuretic 6 5 4
 - ACE-inhibitor 5 5 4
 - Beta receptor antagonist 3 3 3
Hyperlipidemia (total) 2 2 2
 - Statin 2 2 2
Mood disorder (total) 9 6 6
 - SSRI 8 6 6
 - Tricyclic antidepressant 1 0 0
Gastroesophageal reflux disease 2 2 3
 - Omeprazole 2 2 3